Activity enhances dopaminergic long-duration response in Parkinson disease.
about
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohortParadoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.Chronic Nicotine Mitigates Aberrant Inhibitory Motor Learning Induced by Motor Experience under Dopamine Deficiency.Study in Parkinson disease of exercise (SPARX): translating high-intensity exercise from animals to humansThe role of neuroplasticity in dopaminergic therapy for Parkinson disease.A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders.Current and experimental treatments of Parkinson disease: A guide for neuroscientists.Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease.Does positive pressure body weight-support alter spatiotemporal gait parameters in healthy and parkinsonian individuals?Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson's disease patients
P2860
Q28076121-0F68998B-930A-4B41-BF99-770E2762BF62Q35825721-414959E9-B2F2-4A85-BE38-9B30A54F707AQ36889608-C3986E0C-BE97-43A8-9D6D-00DB809FAB5AQ37161380-2DF63FD5-66EB-4EF1-A4D9-EAB073F84823Q38099197-25EEF281-3C8B-47B2-8005-F98D4DA06427Q38391474-00C55FDD-89EE-4130-B9DD-497C43A9A3F7Q38941557-F9FBE4C9-07D4-495D-A2E6-700DBF8EBFECQ47121220-D0B43001-0831-4644-8F82-6B49DD637604Q47234022-145204E8-A95F-492C-B09A-C1CC7DCA7E2FQ58698708-D942E7BA-3C81-4377-BA4B-32E235E9E504
P2860
Activity enhances dopaminergic long-duration response in Parkinson disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Activity enhances dopaminergic long-duration response in Parkinson disease
@nl
Activity enhances dopaminergic long-duration response in Parkinson disease.
@ast
Activity enhances dopaminergic long-duration response in Parkinson disease.
@en
type
label
Activity enhances dopaminergic long-duration response in Parkinson disease
@nl
Activity enhances dopaminergic long-duration response in Parkinson disease.
@ast
Activity enhances dopaminergic long-duration response in Parkinson disease.
@en
prefLabel
Activity enhances dopaminergic long-duration response in Parkinson disease
@nl
Activity enhances dopaminergic long-duration response in Parkinson disease.
@ast
Activity enhances dopaminergic long-duration response in Parkinson disease.
@en
P2093
P2860
P3181
P1433
P1476
Activity enhances dopaminergic long-duration response in Parkinson disease.
@en
P2093
Parkinson Study Group ELLDOPA Investigators
Peggy Auinger
Un Jung Kang
P2860
P304
P3181
P356
10.1212/WNL.0B013E31824F8056
P407
P577
2012-03-28T00:00:00Z